Douglas E Onsi - Net Worth and Insider Trading

Douglas E Onsi Net Worth

The estimated net worth of Douglas E Onsi is at least $1 Million dollars as of 2024-05-04. Douglas E Onsi is the CFO, GC, Treasurer & Secretary, 10% Owner of Leap Therapeutics Inc and owns about 445,869 shares of Leap Therapeutics Inc (LPTX) stock worth over $1 Million. Details can be seen in Douglas E Onsi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas E Onsi has not made any transactions after 2019-02-05 and currently still holds the listed stock(s).

Transaction Summary of Douglas E Onsi

To

Douglas E Onsi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas E Onsi owns 2 companies in total, including Leap Therapeutics Inc (LPTX) , and TetraLogic Pharmaceuticals Corp (TLOG) .

Click here to see the complete history of Douglas E Onsi’s form 4 insider trades.

Insider Ownership Summary of Douglas E Onsi

Ticker Comapny Transaction Date Type of Owner
LPTX Leap Therapeutics Inc 2019-02-05 10 percent owner & CFO,Gen Counsel,Treas & Sec.
TLOG TetraLogic Pharmaceuticals Corp 2015-01-28 director

Douglas E Onsi Latest Holdings Summary

Douglas E Onsi currently owns a total of 1 stock. Douglas E Onsi owns 445,869 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $1 Million.

Latest Holdings of Douglas E Onsi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPTX Leap Therapeutics Inc 2019-02-05 445,869 3.19 1,422,322

Holding Weightings of Douglas E Onsi


Douglas E Onsi Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas E Onsi has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Douglas E Onsi around $999,999.

Insider Trading History of Douglas E Onsi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas E Onsi Trading Performance

GuruFocus tracks the stock performance after each of Douglas E Onsi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas E Onsi is 13.8%. GuruFocus also compares Douglas E Onsi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas E Onsi within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas E Onsi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas E Onsi

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.14
Relative Return to S&P 500(%) 4.77

Douglas E Onsi Ownership Network

Ownership Network List of Douglas E Onsi

No Data

Ownership Network Relation of Douglas E Onsi


Douglas E Onsi Owned Company Details

What does Leap Therapeutics Inc do?

Who are the key executives at Leap Therapeutics Inc?

Douglas E Onsi is the 10 percent owner & CFO,Gen Counsel,Treas & Sec. of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .

Leap Therapeutics Inc (LPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Leap Therapeutics Inc Insider Transactions

No Available Data

Douglas E Onsi Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas E Onsi. You might contact Douglas E Onsi via mailing address: C/o Tolerrx Inc, 300 Technology Square, Cambridge Ma 02139.

Discussions on Douglas E Onsi

No discussions yet.